Anti-VEGF therapy for proliferative diabetic retinopathy: translating research evidence into clinical practice

Anti-VEGF therapy for proliferative diabetic retinopathy: translating research evidence into clinical practice

<p> <br> </p> <p> <b>E.A. Abdulaeva<sup>1</sup>, E.L. Minkhuzina<sup>1,2</sup>,<sup> </sup>A.N. Kuskov<sup>2</sup></b> </p> <p> <b><sup>1</sup></b><...

Full description

Bibliographic Details
Main Authors:	E.A. Abdulaeva, E.L. Minkhuzina, A.N. Kuskov
Format:	Article
Language:	Russian
Published:	Prime-Media 2020-06-01
Series:	РМЖ "Клиническая офтальмология"
Online Access:	http://clinopht.com/upload/iblock/bb2/bb29917b5a48424f9a54887652366006.pdf

Similar Items

ANGIOGENESIS IN PROLIFERATIVE DIABETIC RETINOPATHY: RERSPECTIVES OF ANTI-VEGF THERAPY (REVIEW OF LITERATURE)
by: V. I. Konenkov, et al.
Published: (2015-12-01)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
by: Tyler A. Bahr, et al.
Published: (2023-04-01)

Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
by: Quan Dong Nguyen, et al.
Published: (2023-12-01)

Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients
by: Yue Xu, et al.
Published: (2022-10-01)

Update on imaging and anti-VEGF therapy for diabetic retinopathy
by: Sagnik Sen, et al.
Published: (2022-01-01)

LOCAL AND SYSTEMIC VEGF-А PRODUCTION IN COMPLICATED PROLIFERATIVE DIABETIC RETINOPATHY
by: V. V. Neroev, et al.
Published: (2016-08-01)

Curative effect of 25G vitrectomy combined with different anti-VEGF drugs on proliferative diabetic retinopathy
by: Yan-Xia Shang, et al.
Published: (2022-11-01)

Regression of Neovascularization after Panretinal Photocoagulation Combined with Anti-VEGF Injection for Proliferative Diabetic Retinopathy—A Review
by: Maciej Gawęcki, et al.
Published: (2023-12-01)

Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy
by: Xincheng Sun, et al.
Published: (2023-09-01)

VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
by: Sara Rezzola, et al.
Published: (2021-02-01)

Clinical Course and Results of Anti-VEGF Therapy of Retinopathy of Prematurity
by: L. A. Katargina, et al.
Published: (2021-04-01)

Vitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular statusVitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular status
by: Vira S. Ponomarchuk, et al.
Published: (2021-08-01)

Markers of Proliferative Diabetic Retinopathy
by: V. A. Biletskaya, et al.
Published: (2022-10-01)

VEGF and eNOS genes polymorphism features in patients with diabetes mellitus with and without initial non-proliferative diabetic retinopathy
by: A. V. Shevchenko, et al.
Published: (2021-12-01)

Proliferative diabetic retinopathy in acromegaly
by: Chintan Malhotra
Published: (2010-01-01)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01)

Regularities of the Natural Evolution of the Proliferative Process in Diabetic Retinopathy. The Concept of Remission of Proliferative Diabetic Retinopathy
by: S. V. Sdobnikova
Published: (2021-12-01)

TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy
by: Vincenza Bonfiglio, et al.
Published: (2020-12-01)

Novel therapies for proliferative retinopathies
by: Juan Manuel Martinez-Alejo, et al.
Published: (2022-12-01)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
by: Casey C. Bunge, MD, et al.
Published: (2023-12-01)

Effects of laser combined with Ranibizumab on levels of PAI, t-PA and VEGF in aqueous humor in patients with proliferative diabetic retinopathy
by: Yan Lu, et al.
Published: (2020-01-01)

Conjunctival impression cytology in non-proliferative and proliferative diabetic retinopathy
by: Mehmet Citirik, et al.
Published: (2014-04-01)

Stage R3: Proliferative Diabetic Retinopathy and Advanced Diabetic Retinopathy
by: Scanlon, P
Published: (2009)

EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
by: O. M. Trubina, et al.
Published: (2016-11-01)

WTH FACTORS IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY
by: A. N. Trunov, et al.
Published: (2017-04-01)

VIOLATIONS OF CYTOKINE REGULATION IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY
by: D. V. Chernykh, et al.
Published: (2015-10-01)

Systematic evaluation of combined herbal adjuvant therapy for proliferative diabetic retinopathy
by: Baogeng Huai, et al.
Published: (2023-05-01)

Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma
by: Prajina Rahul, et al.
Published: (2016-01-01)

Features of proliferative process in patients with diabetic retinopathy
by: Dmitriy Valentinovich Lipatov, et al.
Published: (2012-06-01)

The level of VEGF-A in the lacrimal fluid of diabetic retinopathy
by: Yu. A. Borzilova, et al.
Published: (2015-12-01)

Anti-VEGF-therapy for pseudoxanthoma elasticum (case reports)
by: A.D. Chuprov, et al.
Published: (2023-08-01)

Comparing the Axial Length of Eyes in Patients with Proliferative and Non-proliferative Diabetic Retinopathy
by: Farhad Fazel, et al.
Published: (2011-03-01)

HbA1C, proliferative and non-proliferative retinopathy in diabetic patients
by: Faeze Poshtchaman, et al.
Published: (2023-07-01)

Stage R1: Mild Non-Proliferative Diabetic Retinopathy (Background Diabetic Retinopathy)
by: Scanlon, P
Published: (2009)

Progression of pre-proliferative to proliferative diabetic retinopathy: a 3-year study in the Oxford population-based diabetic retinopathy screening programme
by: Muqit, M, et al.
Published: (2014)

Comparison of corneal biomechanics and levels of serum Leptin and extracellular superoxide dismutase in patients with non-proliferative diabetic retinopathy or proliferative diabetic retinopathy
by: Lan Wang, et al.
Published: (2023-11-01)

Vitreous protein networks around ANG2 and VEGF in proliferative diabetic retinopathy and the differential effects of aflibercept versus bevacizumab pre-treatment
by: Ingeborg Klaassen, et al.
Published: (2022-12-01)

Carotid Atherosclerosis and Proliferative Diabetic Retinopathy in Type 2 Diabetics
by: Yiwen CHEN, Xuelian ZHANG
Published: (2022-08-01)

Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy
by: Ahmed M. Abu El-Asrar, et al.
Published: (2022-09-01)

Proliferative diabetic retinopathy in unsuspected diabetes mellitus: a case report
by: O.V. Zborovska, et al.
Published: (2019-04-01)